We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

490 hedge funds and large institutions have $11.5B invested in Bio-Rad Laboratories Class A in 2020 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 177 increasing their positions, 176 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

16% more capital invested

Capital invested by funds: $9.85B → $11.5B (+$1.61B)

3% more funds holding

Funds holding: 478490 (+12)

1.14% more ownership

Funds ownership: 78.38%79.52% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 176

8% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $16M

Holders
490
Holders Change
+12
Holders Change %
+2.51%
% of All Funds
8.67%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
76
Increased
177
Reduced
176
Closed
57
Calls
$14.7M
Puts
$16M
Net Calls
-$1.25M
Net Calls Change
+$4.17M
Name Holding Trade Value Shares
Change
Change in
Stake
COPPSERS
226
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.57M +$403K +708 +36%
ACM
227
Ativo Capital Management
Illinois
$1.52M -$1.71K -3 -0.1%
FAF
228
Första AP-fonden
Sweden
$1.52M +$1.48M +2,600 New
SG Americas Securities
229
SG Americas Securities
New York
$1.5M +$1.04M +1,825 +244%
Caisse de Depot et Placement du Quebec (CDPQ)
230
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$1.48M -$259K -455 -15%
MLM
231
Mount Lucas Management
Pennsylvania
$1.45M +$1.42M +2,489 New
HIMCH
232
Hartford Investment Management Co (HIMCO)
Connecticut
$1.44M +$109K +192 +8%
NAM
233
Nissay Asset Management
Japan
$1.4M +$14.8K +26 +1%
JMPWA
234
JP Morgan Private Wealth Advisors
California
$1.38M -$82K -144 -6%
Ensign Peak Advisors
235
Ensign Peak Advisors
Utah
$1.35M -$499K -877 -27%
FL
236
Fort LP
Maryland
$1.34M +$723K +1,269 +124%
AP
237
AtonRa Partners
Switzerland
$1.33M +$1.3M +2,289 New
OAM
238
Oppenheimer Asset Management
New York
$1.32M -$8.54K -15 -0.7%
LIA
239
LS Investment Advisors
Michigan
$1.26M +$170K +298 +16%
II
240
IFM Investors
Australia
$1.26M +$185K +325 +18%
RJFSA
241
Raymond James Financial Services Advisors
Florida
$1.25M -$212K -372 -15%
SAM
242
Shell Asset Management
Netherlands
$1.22M -$317K -556 -21%
Rockefeller Capital Management
243
Rockefeller Capital Management
New York
$1.22M +$79.7K +140 +7%
Public Sector Pension Investment Board (PSP Investments)
244
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.21M -$408K -716 -26%
SAM
245
Securian Asset Management
Minnesota
$1.21M
GCC
246
Guardian Capital (Canada)
Ontario, Canada
$1.17M +$6.83K +12 +0.6%
VCM
247
Virtue Capital Management
Tennessee
$1.15M -$292K -513 -21%
SMDAM
248
Sumitomo Mitsui DS Asset Management
Japan
$1.12M +$50.1K +88 +5%
M&T Bank
249
M&T Bank
New York
$1.09M +$516K +906 +95%
Bank Julius Baer & Co
250
Bank Julius Baer & Co
Switzerland
$1.08M +$420K +737 +66%

BIO Hedge Fund Activity: Q4 2020 in Review

490 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2020, worth a combined $11.5B — up 16% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new BIO positions and 57 closed out — a net gain of 19 holders — while 177 added to existing stakes and 176 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was GQG Partners, exiting entirely with an estimated $183M sold.

  • 490 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2020, up from 478 in Q3 2020.
  • Funds reported $11.5B of Bio-Rad Laboratories Class A stock for Q4 2020, up 16% quarter-over-quarter.
  • 76 funds opened new Bio-Rad Laboratories Class A positions in Q4 2020 and 57 closed out, a net change of +19 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2020 was Fidelity Investments, an estimated $164M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2020 was GQG Partners, an estimated $183M sold.

Based on aggregated 13F filings for Q4 2020.